ABBOTT LABORATORIES Quarterly Interest Expense in USD from Q1 2010 to Q1 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: Abbott Laboratories quarterly/annual Interest Expense history and growth rate from Q1 2010 to Q1 2024.
Abbott Laboratories Interest Expense for the quarter ending March 31, 2024 was $141M, a 7.84% decline year-over-year.
Abbott Laboratories Interest Expense for the twelve months ending March 31, 2024 was $625M, a 7.76% increase year-over-year.
Abbott Laboratories annual Interest Expense for 2023 was $637M, a 14.2% increase from 2022.
Abbott Laboratories annual Interest Expense for 2022 was $558M, a 4.69% increase from 2021.
Abbott Laboratories annual Interest Expense for 2021 was $533M, a 2.38% decline from 2020.

Interest Expense, Trailing 12 Months (USD)

Interest Expense, Quarterly (USD)

Interest Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$625M	$141M	-$12M	-7.84%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-02
Q4 2023	$637M	$159M	+$5M	+3.25%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-16
Q3 2023	$632M	$166M	+$25M	+17.7%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-01
Q2 2023	$607M	$159M	+$27M	+20.5%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-03
Q1 2023	$580M	$153M	+$22M	+16.8%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-02
Q4 2022	$558M	$154M	+$23M	+17.6%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-16
Q3 2022	$535M	$141M	+$8M	+6.02%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-01
Q2 2022	$527M	$132M	-$2M	-1.49%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022	$529M	$131M	-$4M	-2.96%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-04
Q4 2021	$533M	$131M	-$5M	-3.68%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-16
Q3 2021	$538M	$133M	-$4M	-2.92%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-01
Q2 2021	$542M	$134M	$0	0%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-02
Q1 2021	$542M	$135M	-$4M	-2.88%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-03
Q4 2020	$546M	$136M	-$28M	-17.1%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-17
Q3 2020	$574M	$137M	-$30M	-18%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-03
Q2 2020	$604M	$134M	-$34M	-20.2%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-04
Q1 2020	$638M	$139M	-$32M	-18.7%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-05
Q4 2019	$670M	$164M	-$22M	-11.8%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-18
Q3 2019	$692M	$167M	-$36M	-17.7%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-04
Q2 2019	$728M	$168M	-$42M	-20%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-07-29
Q1 2019	$770M	$171M	-$56M	-24.7%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-04-29
Q4 2018	$826M	$186M	-$60M	-24.4%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-19
Q3 2018	$886M	$203M	-$15M	-6.88%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-10-31
Q2 2018	$901M	$210M	-$4M	-1.87%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-07-31
Q1 2018	$905M	$227M	+$1M	+0.44%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-01
Q4 2017	$904M	$246M	+$93M	+60.8%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-21
Q3 2017	$811M	$218M	+$101M	+86.3%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-31
Q2 2017	$710M	$214M	+$111M	+108%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-01
Q1 2017	$599M	$226M	+$168M	+290%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-02
Q4 2016	$431M	$153M	+$112M	+273%	Oct 1, 2016	Dec 31, 2016	10-K	2019-02-22
Q3 2016	$319M	$117M	+$76M	+185%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-02
Q2 2016	$243M	$103M	+$59M	+134%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-02
Q1 2016	$184M	$58M	+$21M	+56.8%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-03
Q4 2015	$163M	$41M	-$2M	-4.65%	Oct 1, 2015	Dec 31, 2015	10-K	2018-02-16
Q3 2015	$165M	$41M	+$6M	+17.1%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-03
Q2 2015	$159M	$44M	+$8M	+22.2%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-03
Q1 2015	$151M	$37M	+$1M	+2.78%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-04
Q4 2014	$150M	$43M	+$16M	+59.3%	Oct 1, 2014	Dec 31, 2014	10-K	2017-02-17
Q3 2014	$134M	$35M	-$2M	-5.41%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-05
Q2 2014	$136M	$36M	-$4M	-10%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-04
Q1 2014	$140M	$36M	-$5M	-12.2%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-06
Q4 2013	$145M	$27M	+$24.4M	+939%	Oct 1, 2013	Dec 31, 2013	10-K	2016-02-19
Q3 2013	$121M	$37M	-$115M	-75.7%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-06
Q2 2013	$236M	$40M	-$43.3M	-52%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-05
Q1 2013	$279M	$41M	-$41.1M	-50%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-07
Q4 2012	$320M	$2.6M	+$47.7M		Oct 1, 2012	Dec 31, 2012	10-K	2015-02-27
Q3 2012	$272M	$152M	+$27.7M	+22.3%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-07
Q2 2012	$245M	$83.3M	-$50.8M	-37.9%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-08-06
Q1 2012	$295M	$82.1M	-$63.5M	-43.6%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-08
Q4 2011	$359M	-$45.1M	-$196M	-130%	Oct 1, 2011	Dec 31, 2011	10-K	2014-02-21
Q3 2011	$555M	$124M	-$24.8M	-16.6%	Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-07
Q2 2011	$580M	$134M	-$359K	-0.27%	Apr 1, 2011	Jun 30, 2011	10-Q	2012-08-07
Q1 2011	$581M	$146M	+$27.4M	+23.2%	Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-08
Q4 2010	$553M	$151M			Oct 1, 2010	Dec 31, 2010	10-K	2013-02-15
Q3 2010		$149M			Jul 1, 2010	Sep 30, 2010	10-Q	2011-11-04
Q2 2010		$134M			Apr 1, 2010	Jun 30, 2010	10-Q	2011-08-04
Q1 2010		$118M			Jan 1, 2010	Mar 31, 2010	10-Q	2011-05-06

* An asterisk sign (*) next to the value indicates that the value is likely invalid.